Trading Statement

RNS Number : 2423E
Renishaw PLC
27 October 2022
 

Renishaw plc

Trading update

27 October 2022

 

Renishaw plc, the global provider of manufacturing technologies, analytical instruments and medical devices, publishes this trading update for the three months ended 30 September 2022. It contains unaudited information that covers the first quarter of the financial year and the period since.

 

Trading activity

 

 

3 months to 30 September 2022

3 months to 30 September 2021a

Change

 

 

 

 

Manufacturing technologies

£172.8m

£152.3m

+13%

Analytical instruments and medical devices

£7.1m

£5.5m

+29%

Total revenue

£179.9m

£157.8m

+14%


 

 

 

Adjustedb profit before tax

£40.0m

£41.7m

-4%

Statutory profit before tax

£38.6m

£39.3m

-2%

 

Overall Group performance was in line with our expectations for the first quarter of the year.

 

Revenue was £179.9m, compared to £157.8m for the corresponding period last year, with revenue growth in all regions. This includes a £4.0m currency benefit at constant exchange rates, net of hedging.

 

In our Manufacturing technologies business, revenue amounted to £172.8m, compared to £152.3m last year, with strong growth in our core industrial markets. In our Analytical instruments and medical devices business, revenue was £7.1m, compared with £5.5m last year.

 

Adjusted profit before tax for the first quarter amounted to £40.0m (FY2022: £41.7m) and is comparable with our profitability in the final quarter of the previous financial year. The current year includes a net £1.0m gain relating to currency. Statutory profit before tax amounted to £38.6m (FY2022: £39.3m).

 

Financial position

The Group balance sheet remains strong with net cash and bank deposit balances of £258.6m at 30 September 2022 (30 June 2022: £253.2m).

 

Outlook

We have made a positive start to the current year and our order book remains strong. We have, as recently reported, seen a weakening in order intake from the semiconductor and electronics sectors, and general market sentiment is becoming more cautious. In light of this, we are managing costs carefully and focusing on productivity.

 

Overall, we're confident in our strategy and the investments we're making in people and infrastructure to deliver sustainable, long-term growth, and we look forward to the year ahead.

 

The results for the half year ending 31 December 2022 will be released on 2 February 2023.

Will Lee

Allen Roberts

 

Chief Executive

Group Finance Director

 



 

27 October 2022


 



 

Renishaw plc


Registered office

New Mills, Wotton-under-Edge, Gloucestershire, GL12 8JR

Registered number

01106260

Telephone number

+44 (0) 1453 524524

Website

www.renishaw.com

 

 

 

 

 

 

a Results relating to sales of additive manufacturing machines to medical and dental customers are no longer recognised in the Analytical instruments and medical devices operating segment. Comparative figures have been reclassified accordingly, with £3.8m reclassified from Analytical instruments and medical devices to Manufacturing technologies in the 3 months to 30 September 2021.

 

b The adjustment to statutory profit relates to the accounting treatment of certain forward currency contracts used as hedging instruments which do not qualify for hedge accounting as they do not meet the hedge effectiveness criteria set out in the International Accounting Standard IFRS 9 'Financial Instruments'. The Board deems that the adjusted profit before tax better reflects the underlying performance of the Group. The following table reconciles statutory profit before tax to adjusted profit before tax:

 

£'m

3 months to 30 September 2022

3 months to 30 September 2021

 

£'000

£'000

 

 


Statutory profit before tax

38.6

39.3

 

 


Fair value (gains)/losses on financial instruments not eligible for hedge accounting

 


  - reported in revenue

(3.7)

1.3

  - reported in (gains)/losses from the fair value of financial instruments

5.1

1.1

 

 


Adjusted profit before tax

40.0

41.7

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTEAKEKAAAAFFA

Companies

Renishaw (RSW)
UK 100

Latest directors dealings